# Respira Therapeutics, Inc. — Form D

Respira Therapeutics, Inc. of ALBUQUERQUE, NM, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-26. The offering totals $9.4M, of which $9.1M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-04-26
- Form: D
- Accession: 0001704271-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $9.4M
- Amount sold: $9.1M
- Remaining: $302K
- Investors: 3
- Date of first sale: 2017-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-285508

## Issuer

- Name: Respira Therapeutics, Inc.
- CIK: 0001704271
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5901 INDIAN SCHOOL RD NE #107, ALBUQUERQUE, NM, 87110
- Phone: 505-200-9557

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Brian P Birk | Director | Santa Fe, NM |
| David M Blivin | Director | Albuquerque, NM |
| Andrew M Clark | Director | Albuquerque, NM |
| Robert M Curtis | Director | Albuquerque, NM |
| Robert M Curtis | Executive Officer | Albuquerque, NM |
| Matthew P Franklin | Executive Officer | Albuquerque, NM |

## More

- [CIK 1704271 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1704271&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001704271-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.